logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
S

Steven Simoens

ku leuven

64H-index
691Paper Count
1.6WCitation Count
Published Papers 206
Publication Date
logo
Timing and rate of reimbursement for cystic fibrosis modulator therapies in EU countries
errJournal of Cystic Fibrosis
IF6
err2026-07-21
err0
errOAAI
errEnrico Costa; Silvia Girotti; Saif Elayan; Carlo Castellani; Maria Cavaller Bellaubi; Wim Goettsch; Momir Radulović; João Rocha; Pierluigi Russo; Steven Simoens; Christine Leopold
errShare
errSave
Exploring market dynamics of biological including biosimilar treatments for retinal diseases in Europe: An interrupted time-series analysis
errActa Ophthalmologica
IF2.8
err2026-04-30
err0
errOAAI
errElif Car; Isabelle Huys; Steven Simoens; Arnold G. Vulto
errShare
errSave
Addressing clinical uncertainties in ATMP reimbursement: a review of methodological guidelines and European practice
errFrontiers in Pharmacology
IF4.8
err2026-03-12
err0
errOAAI
errLD Lotte Delemarre; IH Isabelle Huys; WV Walter Van Dyck; SS Steven Simoens
errShare
errSave
Ensuring Epidemiological Consistency in Risk-Stratified Cancer Screening Models: A Novel Approach Based on Flemish Breast Cancer Screening
errApplied Health Economics and Health Policy
IF3.3
err2026-02-17
err0
PREAI
errMax Lelie; Bo VandenBulcke; Nick Verhaeghe; Lieven Annemans; Steven Simoens; Koen Putman
errShare
errSave
The health production model and the crucial role of health promotion
errEXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH
IF1.5
err2025-11-01
err0
PREAI
errAnnemans, Lieven; Aeyels, Daan; Bejjani, Gilbert; Briganti, Giovanni; Broeckx, Dirk; Devisch, Ignaas; Verdonck, Pascal; Simoens, Steven
errShare
errSave
Toward Regulatory Convergence and Streamlined Biosimilar Development: Recommendations from an International Qualitative Study
errBioDrugs
IF6.9
err2025-10-21
err0
errOAAI
errElif Car; Liese Barbier; Ingrid Schwarzenberger; Isabelle Huys; Steven Simoens; Arnold G. Vulto
errShare
errSave
Preferences for gene therapy in Duchenne muscular dystrophy: insights from patient and caregiver interviews and attribute development
errFrontiers in Pharmacology
IF4.8
err2025-09-29
err0
errOAAI
errThomas Desmet; Lauren Van Haesendonck; Sophie Vermeire; Eline van Overbeeke; Steven Simoens; Isabelle Huys
errShare
errSave
Correction: The unexploited potential of data systems tracking medicines utilization: an opportunity to improve access to oncology combination therapies
errFrontiers in Pharmacology
IF4.8
err2025-09-05
err0
errOAAI
errSteven Simoens; David Dodwell; Michael Hartevelt; Peter Lindgren; Michele Pistollato; Lisa G. Pont; Caridad Pontes; Alexander Roediger; Antun Sablek; Eric Van Ganse; Qinyi Wang; Chris Wenger; Tim Wilsdon; Entela Xoxi; Brian Godman
errShare
errSave
Barriers to adoption of biosimilar insulins in Europe: A mixed-methods study
errdiabetes obesity metabolism
IF0
err2025-09-01
err0
errOAAI
errElif Car MSc; Garm Habets MSc; Arnold G. Vulto PhD; Lutz Heinemann PhD; Isabelle Huys PhD; Steven Simoens PhD
errShare
errSave
Advanced therapy medicinal products are coming of age: A pipeline analysis of the clinical trial landscape
errDrug Discovery Today
IF7.5
err2025-08-23
err0
PREAI
errMichiel Vanhaeren; Rik Gijsbers; Walter Van Dyck; Isabelle Huys; Steven Simoens
errShare
errSave
The unexploited potential of data systems tracking medicines utilization: an opportunity to improve access to oncology combination therapies
errFrontiers in Pharmacology
IF4.8
err2025-08-20
err0
errOAAI
errSteven Simoens; David Dodwell; Michael Hartevelt; Peter Lindgren; Michele Pistollato; Lisa Pont; Caridad Pontes; Alexander Roediger; Antun Sablek; Eric Van Ganse; Qinyi Wang; Chris Wenger; Tim Wilsdon; Entela Xoxi; Brian Godman
errShare
errSave
Compulsory Licensing as an Instrument to Tackle High Medicine Prices: A Realist Review of Industrial and Health Consequences
errAPPLIED HEALTH ECONOMICS AND HEALTH POLICY
IF3.3
err2025-04-19
err0
PREAI
errSimoens, Steven; Van Dyck, Walter; Janssens, Rosanne; Barbier, Liese; Luyten, Jeroen
errShare
errSave
Caregivers and multidisciplinary team members' perspectives on shared decision making in Duchenne muscular dystrophy: A qualitative study
errORPHANET JOURNAL OF RARE DISEASES
IF3.5
err2025-03-10
err0
errOAAI
errSchoefs, Elise; Desmet, Thomas; Lerinckx, Evelyn; De Waele, Liesbeth; Geuens, Sam; Pelicaen, Conny; Meeus, Luc; Simoens, Steven; Van Audenhove, Chantal; Mommen, Mieke; Janssens, Rosanne; Huys, Isabelle
errShare
errSave
Drawing on collective action theory to foster sustainable biosimilar markets - insights from co-creation workshops with UK and Belgian stakeholders
errEXPERT OPINION ON BIOLOGICAL THERAPY
IF4
err2025-03-01
err0
PREAI
errLacosta, Teresa Barcina; Vulto, Arnold G.; Turk, Florian; Huys, Isabelle; Simoens, Steven
errShare
errSave
Clinical and Socioeconomic Burden of Retinal Diseases: Can Biosimilars Add Value? A Narrative Review
errOPHTHALMOLOGY AND THERAPY
IF3.2
err2025-02-26
err0
errOAAI
errHariprasad, Seenu M.; Holz, Frank G.; Asche, Carl V.; Issa, Amine; Mora, Oriol; Keady, Simon; Rezk, Mourad F.; Sarocco, Phil; Simoens, Steven
errShare
errSave
What role for real-world evidence in market access of biosimilars?
errFRONTIERS IN PHARMACOLOGY
IF4.8
err2025-02-24
err0
errOAAI
errSimoens, Steven; Lockhart, Catherine M.; Courmier, Delphine F.
errShare
errSave
Real-world cost-effectiveness of nirmatrelvir-ritonavir as treatment for SARS-CoV-2 infection in the Belgian setting with omicron variant
errFRONTIERS IN PUBLIC HEALTH
IF3.4
err2025-02-03
err0
errOAAI
errMarbaix, Sophie; Simoens, Steven; Clevenbergh, Philippe; Van Bleyenbergh, Pascal; Liberman, Keliane; Dehenau, Dimitri
errShare
errSave
Towards implementing new payment models for the reimbursement of high-cost, curative therapies in Europe: insights from semi-structured interviews
errFRONTIERS IN PHARMACOLOGY
IF4.8
err2025-01-20
err0
errOAAI
errDesmet, Thomas; Michelsen, Sissel; van den Brande, Elena; Van Dyck, Walter; Simoens, Steven; Huys, Isabelle
errShare
errSave
Mitigating the Nocebo Effect in Biosimilar Use and Switching: A Systematic Review
errPHARMACEUTICAL MEDICINE
IF4.5
err2024-11-29
err0
errOAAI
errCar, Elif; Vandenplas, Yannick; Lacosta, Teresa Barcina; Simoens, Steven; Huys, Isabelle; Vulto, Arnold G.; Barbier, Liese
errShare
errSave
The broader benefits of vaccines: methodologies for inclusion in economic evaluation
errEXPERT REVIEW OF VACCINES
IF4.8
err2024-09-04
err1
errOAAI
errSimoens, Steven; Tubeuf, Sandy; Dauby, Nicolas; Ethgen, Olivier; Marbaix, Sophie; Willaert, Marjan; Luyten, Jeroen
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
G
Giuseppe Remuzzi
H-index: 201 · Papers: 2.1K
S
Stefan Schreiber
H-index: 192 · Papers: 1.9K
S
Séverine Vermeire
H-index: 163 · Papers: 2.4K
P
Paul Emery
H-index: 158 · Papers: 1.6K
S
Silvio Danese
H-index: 139 · Papers: 2.3K
View more